Senior insider sale
Chief Medical Officer at PROTAGONIST THERAPEUTICS, INC — senior position signals high conviction
$2.52M
30.38K shares
What this filing means
MOLINA ARTURO MD plans to sell 30.38K shares of PROTAGONIST THERAPEUTICS, INC valued at approximately $2.52M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/26/2026ACC: 0001950047-26-000681
Officer· Chief Medical Officer
Since Jan 2026
30.38K
Shares to sell
$2.52M
Approx. market value
5K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Stock option exercise
Cash
1/26/2026
5KTotal acquired5K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/26/2026 | Stock option exercise Cash | 5K | — |
| Total | 5K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
13.15K
Market value
$1.10M
1/23/2026
—Completed
Units to sell
9.51K
Market value
$784.7K
1/20/2026
—Completed
Units to sell
2.71K
Market value
$229.9K
11/18/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
5K
Market value
$411.4K
1/26/2026
Total
Units
30.38K
Value
$2.52M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/23/2026 | 13.15K | $1.10M | — | Completed |
1/20/2026 | 9.51K | $784.7K | — | Completed |
11/18/2025 | 2.71K | $229.9K | — | Completed |
| Planned — Approximate Date | ||||
1/26/2026 | 5K | $411.4K | NASDAQ | Planned |
| Total | 30.38K | $2.52M | ||